首页> 美国卫生研究院文献>Oncotarget >Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma

【2h】

Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma

机译：经肝动脉化疗栓塞与索拉非尼在晚期肝细胞癌患者中的作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAlthough sorafenib is considered standard therapy for advanced hepatocellular carcinoma (HCC), actual treatments vary. We evaluated the effects of different treatment strategies on overall survival.

机译：尽管索拉非尼被认为是晚期肝细胞癌（HCC）的标准治疗方法，但实际治疗方法却有所不同。我们评估了不同治疗策略对总体生存的影响。

著录项

期刊名称 Oncotarget
作者
Yeonjung Ha; Danbi Lee; Ju Hyun Shim; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Sook Ryun Park; Min-Hee Ryu; Baek-Yeol Ryoo; Yoon-Koo Kang; Kang Mo Kim;
展开▼
作者单位

展开▼
年(卷),期 2016(7),45
年度 2016
页码 74303–74313
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;细胞生物学;
关键词
hepatocellular carcinoma portal vein invasion sorafenib overall survival transarterial chemoembolization;

机译：肝细胞癌;门静脉侵犯;索拉非尼;总体生存率;经动脉化学栓塞;

相似文献

外文文献
中文文献
专利

1. Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial [J] . Park Joong-Won, Kim Yoon Jun, Kim Do Young, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2019,第4期

机译：索拉非尼与晚期肝细胞癌患者有或没有同时曲调化疗栓塞：III期STAH试验
2. Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study [J] . Chien Shih-Chieh, Chen Chiung-Yu, Cheng Pin-Nan, Liver cancer. . 2019,第3期

机译：基于常规栓塞/化疗栓塞的型型血管症型患者患者患者的生存率延长了先进的肝细胞癌和保存肝功能：倾向分数匹配研究
3. Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients [J] . Kai Zhang, Xiangyang Sun, Fubo Xie, Journal of Cancer Research and Therapeutics . 2018,第1期

机译：晚期肝细胞癌患者经动脉化疗栓塞后索拉非尼给药的疗效及对策
4. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Comparison of Treatment Safety and Patient Survival in Elderly versus Nonelderly Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib Combined with Transarterial Chemoembolization: A Propensity Score Matching Study [O] . Hao Hu, Zhenhua Duan, Xiaoran Long, -1

机译：接受索拉非尼联合经动脉化疗栓塞治疗的晚期和晚期肝细胞癌老年和非老年患者的治疗安全性和患者生存率比较：倾向得分匹配研究
7. Comparison of treatment safety and patient survival in elderly versus nonelderly patients with advanced hepatocellular carcinoma receiving sorafenib combined with transarterial chemoembolization: a propensity score matching study. [O] . Hao Hu, Zhenhua Duan, Xiaoran Long, 2015

机译：接受索拉非尼联合经动脉化疗栓塞的老年人与非老年晚期肝细胞癌患者的治疗安全性和患者生存率的比较：倾向评分匹配研究。

Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅